< Back to scientific publications

Magazine 5.1

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors

Authors: Benedetta Stefanini et al

Date: 22 Nov 2023

Scope of interest: hepatological




You may also be interested in:

Report/Poster of Convention/Congress Act

Weak groups of the ABO system: incidence in the population related to the SIMT of Frosinone in 2 years

Authors: M.C. De Nicolò, C.D'amico, D.Gadaleta, G.Guiducci, E.Gigliotti, F.Docimo, M.Schifalacqua, A.Ricci, B.Giorgi, C.Gargiulo.

Date: 2020

Scope of interest: Clinical pathology


Read details
Report/Poster of Convention/Congress Act

Capillary leak syndrome in haematological patients: management and treatment rerospective evaluation

Authors: Postorino M., Rossi R., Zizzari A. G., Marchesi F., Provenzano I., Franceschini L., Pupo L., Rizzo M., Giannì L., Gumenyuk S., De Santis G., Renzi D., Guiducci G., Fiorelli E., Coniglione F., Puliti R., Berrini A., Dauri M.

Date: 2012

Scope of interest: Haematology


Read details
Magazine 2.07

“Antimicrobial properties of platelet rich plasma”.

Authors: Ferraro AS, Ronci C, Lanti A, Docimo F, Adorno G

Date: 2014

Scope of interest: CLINICAL PATHOLOGY


Read details